So they're developing potency assays. That's good, that's what the FDA wants.
But what I'm saying is we haven't had any word of progress or how they intend to overcome the innate difficulties involved in assays for MSCs - this is the issue.
Throwing ten million at the problem is great. But it's a problem money may not be able to solve, and we've been in the dark with regards to details for over a year.
MSB Trading 2021 - paradigm shift, page-7825
-
- There are more pages in this discussion • 2,386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |